MedTrace Logo

Understanding Hallucinations (Part I)

NCT01907568 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 700

Last updated 2016-10-26

No results posted yet for this study

Summary

Psychotic symptoms (hallucinations and delusions) are present in several psychiatric and neurological disorders as well as in the general population. Effective treatment strategies for these symptoms in all patients are lacking and treatment-response can presently not be predicted. To date, the exact pathophysiological mechanism of these symptoms remains unknown. By investigating (subtypes) of hallucinations and delusions in all populations, a common pathway may be found, leading to more effective treatment options. Alternatively, different subtypes may be associated with different pathophysiological mechanisms.

Conditions

Sponsors & Collaborators

  • University Medical Center Groningen

    collaborator OTHER

  • Free University Medical Center

    collaborator OTHER

  • Parnassia Groep

    collaborator OTHER

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Iris Sommer, Prof, MD, PhD · UMC Utrecht

  • Teus van Laar, MD, PhD · UMC Groningen

  • Philip Scheltens, Prof, MD, PhD · Amsterdam UMC, location VUmc

  • Karin Slotema, MD, PhD · Parnassia Groep

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2017-01-31
Completion
2018-01-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01907568 on ClinicalTrials.gov